Judge Rejects Plea Deal On Guidant Heart Device
-NYTimes
04/28/2010 - A federal judge in Minnesota on Tuesday rejected a plea agreement between the federal government and the Guidant Corporation, saying that the deal did not hold the company sufficiently accountable for an episode in which it sold potentially defective heart defibrillators. More>>>
National class action certified against Guidant/Boston Scientific
-TradingMarkets
05/14/2009 - In a decision released May 8, 2009, Justice Cullity of the Ontario Superior Court of Justice certified a national class action against Guidant Corporation (subsequently purchased by Boston Scientific) on behalf of a class of 28, 443 individuals for claims relating to allegedly defective pacemakers. Litigation in the U.S. resulted in a settlement of $240 million in late 2007 on behalf of approximately 8,000 plaintiffs. More>>>
Doctor Criticizes Test Guidelines for New Defibrillator
-NewsInferno
12/14/2008- Dr. Robert Hauser of the Minneapolis Heart Institute Foundation has said in today’s New England Journal of Medicine that he is not confident in the test guidelines for a next-generation heart defibrillator under development by Medtronic, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc., reports the StarTribune.com. More>>>
Boston Scientific Has Loss on Legal Expenses, Cuts
-Bloomberg
02/04/2008 - Boston Scientific Corp., the world's second-largest maker of heart devices, posted a loss on costs for legal expenses and job cuts. Sales rose more than analysts' estimated, boosting the shares in extended trading. More>>>
Boston Scientific posts Q4 net loss on charges
-Reuters
02/04/2008 - Medical device maker Boston Scientific Corp posted a fourth-quarter net loss on Monday as it took charges for restructuring operations, divesting assets and patent litigation. The company, which has focused on reducing costs and shedding non-core assets as it copes with downturns in its two key heart device markets, said the net loss was $458 million, or 31 cents a share. More>>>
Boston Scientific amends Guidant settlement, to pay $240 mln
-Reuters
11/19/2007 - Medical device maker Boston Scientific Corp said it would pay up to $240 million to settle numerous legal claims related to the recall of implantable heart defibrillators made by Guidant Corp, which it acquired last year. More>>>
Boston Scientific reaches amended agreement to settle Guidant product claims
-CNN
11/19/2007 - Boston Scientific (NYSE:BSX) Corp. Monday said it reached an amended agreement to settle for $240 million claims related to product communications issued by Guidant Corp. in 2005 and 2006. More>>>
Boston Scientific Ups Settlement
-wbur.org
11/19/2007 - Boston Scientific is agreeing to pay another $45 million as part of a major settlement with thousands of heart patients over potentially faulty defibrillators. More>>>
Guidant Adds $45 Million to Defibrillator Settlement
-Bloomberg
10/31/2007 - Boston Scientific Corp.'s Guidant unit agreed to pay at least $240 million to settle claims it hid defects in its heart defibrillators, $45 million more than a settlement proposed in July, people with direct knowledge of the accord said. More>>>
Ohio settles with medical manufacturer for $390K
- Columbus Business Journal
09/10/2007 - Ohio has been awarded $390,000 in a multistate, million-dollar settlement with a cardiac defribrillator manufacturer. More>>>
Court sides with locals in Guidant suit
-Indianapolis Business Journal
09/21/2007 - The state's second-highest appeals court is allowing a class-action lawsuit involving Guidant Corp. defibrillators to proceed in Marion County, though the ruling won't affect similar federal or state suits. More>>>
Boston Scientific Will Settle
- Wall Street Journal
08/31/2007 - Boston Scientific Corp. agreed to pay $16.8 million to 35 states and the District of Columbia over allegations that its Guidant unit concealed flaws in its defibrillators. More>>>
Guidant's defibrillator complaints get settled
- The Star Ledger
08/31/2007 - Boston Scientific yesterday agreed to pay $16.7 million to 35 states, including New Jersey, to resolve allegations physicians and patients were not properly notified about wiring problems with an implantable heart defibrillator. More>>>
Guidant settles with states over faulty defibrillators
- Tampa Bay Business News
08/31/2007 - Florida is one of 35 states that have reached a settlement with Guidant Corp. over defective implantable defibrillators. Guidant will pay $16.75 million to the states for consumer education and will implement safety programs and report any future problems with the devices.
More>>>
Washington Attorney General Announces $17 Million Settlement With Heart Defibrillator Manufacturer Guidant Corp.
08/30/2007 - Washington Attorney General Rob McKenna today announced a $16.75 million multistate settlement with Guidant Corporation that extends a replacement program for certain heart defibrillators built prior to November 2002. More>>>
Boston Scientific Fails to Have Punitive Charges Dismissed
06/13/2007 - A federal court Tuesday ruled against Boston Scientific's attempts to have litigation over faulty defibrillators thrown out of court. More >>>
Study: Defibrillators Iffy 10 Years After Implant
05/01/2007 - One in five implanted devices used to shock hearts back into a normal rhythm fails to work properly after 10 years, a study has found. More >>>
Thousands of Devices For Hearts Are Recalled
-NY Times
06/27/2006 - Boston Scientific said yesterday that it was recalling 23,000 heart pacemakers and defibrillators and recommended that 27,000 patients who already have the devices in their chests consult their doctors.
More >>>
Boston Scientific Feels Guidant's Pain
06/27/2006 - Boston Scientific (BSX:NYSE) is recalling a group of pacemakers and defibrillators, all of which were made by the business that used to be the stand-alone company Guidant, because the devices could fail.The recall covers the Insignia and Nexus pacemakers, Contak Renewal TR/TR2 cardiac re synchronization pacemakers and Ventak Prizm 2, Vitality and Vitality 2 implantable cardioverter defibrillators. The products are made by Boston Scientific's cardiac rhythm management group that was formerly part of Guidant. More >>>
Guidant Pacemakers and Implantable Cardiac Difibrillators Malfunction
- FDA
Guidant INSIGNIA and NEXUS Pacemakers
Guidant CONTAK RENEWAL TR/TR2 Cardiac Re synchronization Therapy Pacemakers
Guidant VENTAK PRIZM 2, VITALITY and VITALITY 2 Implantable Cardioverter Defibrillators
Audience: Cardiac healthcare professionals, risk managers and biomedical engineers
[Posted 06/26/2006] Guidant and FDA notified healthcare professionals and patients that a subset of implantable pacemakers, cardiac re synchronization therapy pacemakers and implantable cardioverter defibrillators [ICD's] is associated with five reports of device malfunction due to the failure of a low-voltage capacitor from a single component supplier. Patients with affected pacemakers may experience intermittent or permanent loss of output or telemetry or premature battery depletion. Patients with affected ICD's may experience inappropriate sensing or premature battery depletion. Physicians are asked to perform an exam as soon as possible to assess device function for all patients with implanted devices from this subset.
[June 26, 2006 – Press Release – Boston Scientific/Guidant]
[June 23, 2006 – Letter to Physicians – Guidant]
[June 23, 2006 – Letter to Patients – Guidant]
Guidant Never Sent Letter Warning About Devices
- NY Times
06/07/2006 - - Newly released records show that Guidant Corp. drafted a letter last year to tell doctors about significant defects in the company's heart devices but never sent it, a report said on Wednesday. More >>>
Boston Scientific Warns About Faulty Guidant Defibrillators
-Business Journal
05/17/2006 -
Boston Scientific Corp. has warned physicians that 996 defibrillators made by its Guidant unit may quit prematurely, leaving heart-failure patients without protection against sudden cardiac death. More >>>
Panel cites Guidant patient-safety lapses - NYT
-Reuters
03/21/2006 - A panel chosen by Guidant Corp to review its handling of heart-device flaws has found the company systemically failed to fully assess patient safety in deciding whether to publicize product failures, the New York Times said on Tuesday. More >>>
Guidant warns about voltage problem with defibrillators
-Reuters
03/14/2006 - Guidant Corp. cautioned doctors Monday to check the voltage on certain implantable defibrillators after the company received several reports of defective devices. More >>>
Deaths no higher with recalled heart devices-stud
-Reuters
03/13/2006 - Patients with implanted heart devices that were subject to U.S. recalls or
safety warnings do not have higher death rates than those who had devices that
were not linked to such problems, a study released on Monday said. More >>>
Internal Turmoil at Device Maker as Inquiry Grew
-NY Times
02/28/2006 - As the Guidant Corporation came under scrutiny last spring for not telling
doctors about potentially fatal defects in its heart devices, the company's
public message was upbeat and insistent: concerns about the safety of its
products were overblown, it said, and perhaps even irresponsible. More >>>
2500 May Seek Damages
-Indianapolis Star
02/23/2006 - Guidant Corp. said as many as 2,500 patients may seek damages following last year's recall of 109,000 implantable defibrillators linked to at least seven deaths. Guidant, the second-largest maker of the devices that correct abnormal heart rhythms, said in a filing Wednesday that it learned last month of about 1,700 claims and expects more. Those claims are distinct from patients already participating in 211 individual and class-action lawsuits in the U.S. and Canada, the company said. More >>>
Deposition sheds light on Guidant defibrillator case
-Indy Star
02/22/2006 - After a Guidant Corp. defibrillator failed to jolt a Minnesota student's heart back to life during cardiac arrest last year, the victim's doctors demanded an explanation from the Indianapolis medical device maker. More >>>
Guidant Issues Warning on Pacemakers
-Bloomberg News
01/24/2006 - The Guidant Corporation, the object of a bidding war between Johnson & Johnson and Boston Scientific, said yesterday that doctors should consider replacing cardiac pacemakers implanted in about 19,300 patients worldwide. More >>>